Revenue and Growth - FY 2024 revenue reached 7.4billion,up121.9 billion, a 9% increase year over year, primarily due to a 13% growth in the commercial aerospace sector[7] - FY 2025 revenue growth guidance has been raised to approximately 8% year over year[17] - Sales for 2024 increased to 7,430million,up11.96,640 million in 2023[47] - Q4 2023 sales reached 1,731million,withaprojectedincreaseto1,891 million in Q4 2024, representing a growth of 9.7%[69] - The company anticipates a total sales increase from 6,640millionin2023to7,430 million in 2024, reflecting a growth of 11.9%[69] Net Income and Earnings - Net income for FY 2024 was 1.2billion,or2.81 per share, compared to 765million,or1.83 per share, in FY 2023[14] - Net income rose to 1,155millionin2024,a51.0765 million in 2023[47] - Basic earnings per share (EPS) increased to 2.83in2024,up53.01.85 in 2023[47] - Net income for Q4 2024 is expected to reach 314million,withatotalof1,155 million for the year[56] - Total net income excluding special items for the year ended December 31, 2023, was 766million,withadilutedEPSof1.84[60] Cash Flow and Capital Management - Free cash flow for FY 2024 was 977million,representingan88190 million of common stock in Q4 2024, totaling 500millionforthefullyear2024,retiringapproximately5.8millionshares[28]−Thecompanyrepurchased500 million of common stock in 2024, up from 250millionin2023[51]−FreecashflowforQ42024isprojectedtobe378 million, contributing to a total of 977millionfortheyear[56]−Freecashflowconversionasapercentageofnetincomefor2024isprojectedat853.7 billion, up 14% year over year, with an adjusted EBITDA margin of 30.8%[20] - Fastening Systems segment revenue for FY 2024 was 1.6billion,up17243 million, a 12% decrease year over year due to lower volumes in the commercial transportation market[25] - Full year 2024 revenue was 1.1billion,down81,587 million, with a projected increase to 2,009millionin2024[54]ExpensesandInvestments−AdjustedEBITDAforFY2024was1.9 billion, up 27% year over year, with an adjusted EBITDA margin of 25.8%[16] - Capital expenditures for 2024 were 321million,comparedto219 million in 2023, indicating a 46.5% increase[51] - Research and development expenses slightly decreased to 33millionin2024from36 million in 2023[47] Debt and Financial Obligations - In 2024, the company reduced gross debt by 365million,resultinginannualizedinterestexpensesavingsofapproximately37 million[32] - Long-term debt decreased to 3,309millionin2024from3,500 million in 2023, a reduction of 5.5%[50] Dividends and Shareholder Returns - The quarterly dividend was increased by 25% to 0.10persharestartingQ12025[12]−Thequarterlycommonstockdividendwasincreasedby250.10 per share for Q1 2025, following a dividend of 0.08pershareinQ42024[33]FutureOutlookandGuidance−Q12025guidanceforrevenuerangesfrom1.925 billion to 1.945billion,withAdjustedEBITDAguidancebetween515 million and 525million[35]−ThecompanyplanstoholditsquarterlyconferencecallonFebruary13,2025,todiscussfinancialperformanceandfutureoutlook[36]−Thecompanyanticipatescontinuedgrowthinsalesandoperatingincome,drivenbymarketexpansionandnewproductdevelopments[68]OperationalPerformance−Theoperatingincomemarginimprovedfrom18.823 million and costs associated with closures of 13million[66]−Thecompanyreportedanetbenefitof44 million related to additional U.S. federal and state R&D credits claimed for prior years in YTD 2024[67] - Future periods may still incur additional special items, but management believes it is appropriate to consider both GAAP and non-GAAP measures[69]